EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Optimized methods for the targeted surveillance of extended-spectrum beta-lactamase-producing Escherichia coli in human stool

Sarah Gallichan iD, Sally Forrest, Esther Picton-Barlow, Claudia McKeown, Maria Moore, Eva Heinz iD, Nicholas A Feasey, Joseph M Lewis, Fabrice E Graf iD

Microbiology Spectrum · 07.01.2025 · 13 (1)

DOI: 10.1128/spectrum.01058-24 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Microbiology Spectrum, erschienen am 07.01.2025. Verfasst von Sarah Gallichan und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Sciences, Liverpool School of Tropical Medicine, Liverpool, United Kingdom. Hauptthemen laut MEDLINE: Feces, Escherichia coli, beta-Lactamases, Escherichia coli Infections. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: UK Research and Innovation (UKRI), Unilever (U), NIHR Global Health Professorship.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Understanding transmission pathways of important opportunistic, drug-resistant pathogens, such as extended-spectrum beta-lactamase (ESBL)-producing Escherichia coli , is essential to implementing targeted prevention strategies to interrupt transmission and reduce the number of infections. To link transmission of ESBL-producing E. coli (ESBL-EC) between two sources, single-nucleotide resolution of E. coli strains, as well as E. coli diversity within and between samples, is required. However, the microbiological methods to best track these pathogens are unclear. Here, we compared different steps in the microbiological workflow to determine the impact different pre-enrichment broths, pre-enrichment incubation times, selection in pre-enrichment, selective plating, and DNA extraction methods had on recovering ESBL-EC from human stool samples, with the aim to acquire high-quality DNA for sequencing and genomic epidemiology. We demonstrate that using a 4-h pre-enrichment in Buffered Peptone Water, plating on cefotaxime-supplemented MacConkey agar and extracting DNA using Lucigen MasterPure DNA Purification kit improves the recovery of ESBL-EC from human stool and produced high-quality DNA for whole-genome sequencing. We conclude that our optimized workflow can be applied for single-nucleotide variant analysis of an ESBL-EC from stool. IMPORTANCE Drug-resistant infections are increasingly difficult to treat with antibiotics. Preventing infections is thus highly beneficial. To do this, we need to understand how drug-resistant bacteria spread to take action to stop infection and transmission. This requires us to accurately trace these bacteria between different sources. In this study, we compared different laboratory methods to see which worked best for detecting extended-spectrum beta-lactamase (ESBL)-producing E. coli , a common cause of urinary tract or bloodstream infections, from human stool samples. We found that enriching stool in a nutrient broth for 4 h, then plating the bacterial suspension on antibiotic-selective MacConkey agar, and finally extracting DNA from the bacteria using a specific DNA purification kit resulted in improved recovery of ESBL E. coli and high-quality DNA. Sequencing multiple isolates from stool allowed us to distinguish unambiguously and at high resolution between different variants of ESBL E. coli present in stool.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FecesEscherichia colibeta-LactamasesEscherichia coli InfectionsHumansAnti-Bacterial AgentsWhole Genome Sequencing

Stichwörter der Autor:innen

DNA extractionantimicrobial resistancemicrobiological methodsmolecular epidemiologysurveillancetransmission

Substanzen

beta-LactamasesAnti-Bacterial Agents

Autor:innen und Institutionen

  • Department of Clinical Sciences, Liverpool School of Tropical Medicine, Liverpool, United Kingdom.
  • Department of Vector Biology, Liverpool School of Tropical Medicine, Liverpool, United Kingdom.
  • Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, Glasgow, United Kingdom.
  • The School of Medicine, University of St Andrews, St Andrews, United Kingdom.
  • Department of Clinical Infection, Microbiology and Immunology, University of Liverpool, Liverpool, United Kingdom.

ORCID-Profile: Sarah Gallichan, Eva Heinz, Fabrice E Graf

Förderung

  • UK Research and Innovation (UKRI)
  • Unilever (U)
  • NIHR Global Health Professorship

Zitieren

APA

Gallichan, S., Forrest, S., Picton-Barlow, E., McKeown, C., Moore, M., Heinz, E., Feasey, N. A., Lewis, J. M., & Graf, F. E. (2025). Optimized methods for the targeted surveillance of extended-spectrum beta-lactamase-producing Escherichia coli in human stool. Microbiology Spectrum, 13(1). https://doi.org/10.1128/spectrum.01058-24

Vancouver

Gallichan S, Forrest S, Picton-Barlow E, McKeown C, Moore M, Heinz E, et al. Optimized methods for the targeted surveillance of extended-spectrum beta-lactamase-producing Escherichia coli in human stool. Microbiology Spectrum. 2025;13(1). doi:10.1128/spectrum.01058-24

BibTeX
@article{Gallichan2025,
  author = {Gallichan, Sarah and Forrest, Sally and Picton-Barlow, Esther and McKeown, Claudia and Moore, Maria and Heinz, Eva and Feasey, Nicholas A and Lewis, Joseph M and Graf, Fabrice E},
  title = {Optimized methods for the targeted surveillance of extended-spectrum beta-lactamase-producing Escherichia coli in human stool},
  journal = {Microbiology Spectrum},
  year = {2025},
  volume = {13},
  number = {1},
  doi = {10.1128/spectrum.01058-24}
}
Kostenlos starten →